OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 4
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 4
Showing 4 citing articles:
Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 7
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 7
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access
Discovery of novel 2,4-diarylaminopyrimidine hydrazone derivatives as potent anti-thyroid cancer agents capable of inhibiting FAK
Hongting Li, Mei-Qi Jia, Zhao-Long Qin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Hongting Li, Mei-Qi Jia, Zhao-Long Qin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
